Studies on the antidiabetic activities of Momordica charantia fruit juice in streptozotocin-induced diabetic rats

References

• Ahmed I, Adeghate E, Sharma AK, Pallot DJ, Singh J. 1998 . Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Res Clin Pract. 40:145–151.
   PubMed Web of Science ®Google Scholar
• Ahmed I, Adeghate E, Cummings E, Sharma AK, Singh J. 2004 . Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat. Mol Cell Biochem. 261:63–70.
   PubMed Web of Science ®Google Scholar
• Armbruster DA. 1987. Fructosamine: structure, analysis, and clinical usefulness. Clin Chem. 33:2153–2163.
   PubMed Web of Science ®Google Scholar
• Beutler E, Dubon O, Kelly BM. 1963 . Improved method for the determination of blood glutathione. J Lab Clin Med. 61:882–890.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National diabetes fact sheet. 2007. General information and national estimates on diabetes in the United States, Atlanta, GA: U.S. Department of Health and Human Services.
   Google Scholar
• Chaturvedi P. 2009. Bitter melon protects against lipid peroxidation caused by immobilization stress in albino rats. Int J Vitam Nutr Res. 79: 48–56.
   PubMed Web of Science ®Google Scholar
• Chen Q, Chan LL, Li ET. 2003 . Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet. J Nutr. 133:1088–1093.
   PubMed Web of Science ®Google Scholar
• Cummings E, Hundal HS, Wackerhage H, Hope M, Belle M, Adeghate E, Singh J. 2004 . Momordica charantia fruit juice stimulates glucose and amino acid uptakes in L6 myotubes. Mol Cell Biochem. 261:99–104.
   PubMed Web of Science ®Google Scholar
• Day C, Cartwright T, Provost J, Bailey CJ. 1990. Hypoglycaemic effect of Momordica charantia extracts. Planta Med. 56:426–429.
   PubMed Web of Science ®Google Scholar
• Dhar P, Chattopadhyay K, Bhattacharyya D, Roychoudhury A, Biswas A, Ghosh S. 2006. Antioxidative effect of conjugated linolenic acid in diabetic and non-diabetic blood: an in vitro study. J Oleo Sci. 56:19–24.
   PubMedGoogle Scholar
• Feldman H, Roadbard D. 1971. Mathematical theory of radioimmunoassay. In: Odell WD, Doughaday WH, editors, Principles of Competitive Protein-Binding Assays. Philadelphia: J.B. Lippincott Company. 158–203.
   Google Scholar
• Fernandes NP, Lagishetty CV, Panda VS, Naik SR. 2007. An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extracts. BMC Complement Altern Med. 24:7–29.
   Google Scholar
• Garau C, Cummings E, Phoenix DA, Singh J. 2003. Beneficial effect and mechanism of action of Momordica charantia in the treatment of diabetes mellitus: a mini review. Int J Diabetes Metab. 11:46–55.
   Google Scholar
• Ghosh R, Sharatchandra KH, Rita S, Thokchom IS. 2004. Hypoglycemic activity of Ficus hispida (bark) in normal and diabetic albino rats. Indian J Pharmacol. 36:222–225.
   Google Scholar
• Grodsky GM, Epstein GH, Fanska R, Karam JH. 1977. Pancreatic action of the sulfonylureas. Fed Proc. 36:1714–1719.
   PubMedGoogle Scholar
• Hellman B, Lernmark A, Sehlin J, Taljedal IB. 1973. Pancreatic β-cell recognition of insulin secretagogues. Inhibitory effects of a membrane probe on the islet uptake and insulin-releasing action of glibenclamide. FEBS Lett. 34:347–349.
   PubMed Web of Science ®Google Scholar
• Joseph B, Jini D. 2013. Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pacific J Trop Dis. 3:93–102.
   Google Scholar
• Karunanayake EH, Tennekoon KH. 1993. Search of novel hypoglycemic agents from medicinal plants. In: Diabetes Mellitus and Its Complications, A.K. Sharma, editor. New Delhi, India: Macmillan India Ltd. p. 192–205.
   Google Scholar
• Koebnick C, Garcia AL, Dagnelie PC, Strassner C, Lindeman J, Katz N, Leitzmann C, Hoffmann I. 2005. Long-term consumption of a raw food diet is associated with favorable serum LDL cholesterol and triglycerides but also with elevated plasma homocysteine and low serum HDL cholesterol in humans. J Nutr. 135:2372–2378.
   PubMed Web of Science ®Google Scholar
• Koracevic D, Koracevic G, Djordjevic G, Andrejevic S, Cosic V. 2001. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol. 54:356–361.
   PubMed Web of Science ®Google Scholar
• Kumar DS, Sharathnath KV, Yogeswaran P, Harani A, Sudhakar K, Sudha P, Banji D. 2010. A medicinal potency of Momordica charantia. Int J Pharma Sci Rev Res. 1:018.
   Google Scholar
• Matsui S, Yamane T, Takita T, Oishi Y, Kobayashi-Hattori K. 2013. The hypocholesterolemic activity of Momordica charantia fruit is mediated by the altered cholesterol- and bile acid-regulating gene expression in rat liver. Nutr Res. 33:580–585.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:412–419.
   PubMed Web of Science ®Google Scholar
• Miura T, Itoh C, Iwamoto N, Kato M, Kawai M, Park SR, Suzuki I. 2001. Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice. J Nutr Sci Vitaminol. 47:340–344. (Tokyo)
   PubMed Web of Science ®Google Scholar
• Nerurkar VR. 2005. Microsomal triglyceride transfer protein gene expression and ApoB secretion are inhibited by bitter melon in HepG2 cells. J Nutr. 135:702–706.
   PubMed Web of Science ®Google Scholar
• Ng TB, Wong CM, Li WW, Yeung HW. 1986. Insulin-like molecules in Momordica charantia seeds. J Ethnopharmacol. 15:107–117.
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi Ν, Yagi Κ. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:351–358.
   PubMed Web of Science ®Google Scholar
• Palaian AK, Chhetri M, Prabhu S, Rajan SP. 2005. Role of pharmacist in counseling diabetes patients. Internet J Pharmacol. 4:1–13.
   Google Scholar
• Petlevski R, Hadzija M, Slijepcevic M, Juretic D. 2000 . Effect of ‘antidiabetis’ herbal preparation on serum glucose and fructosamine in NOD mice. J Ethnopharmacol. 75:181–184.
   Web of Science ®Google Scholar
• Rang HP, Dale MM. 1991 The endocrine system. In: Pharmacology, 2nd ed. Harlow: Longman. Group Ltd. 6. p. 504–508
   Google Scholar
• Rotshteyn Y, Zito SW. 2004. Application of modified in vitro screening procedure for identifying herbals possessing sulfonylurea-like activity. J Ethnopharmacol. 9:337–344.
   Google Scholar
• Sarkar S, Pranava M, Marita R. 1996. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol Res. 33:1–4.
   PubMed Web of Science ®Google Scholar
• Sathishsekar D, Subramanian S. 2005. Beneficial effects of Momordica charantia seeds in the treatment of STZ-induced diabetes in experimental rats. Biol Pharm Bull. 28:978–983.
   PubMed Web of Science ®Google Scholar
• Schemer S. 1967. The blood morphology of laboratory animals, 3rd ed. Philadephia, USA: Davis–FA Company; 42.
   Google Scholar
• Sharma AK, Ahmed I, Tadayyon M, Ponery AS, Aloamaka P, Absood G, Pallot DJ. 1995. The beneficial effects of Momordica charantia fruit juice on streptozotocin induced diabetes and hypertension in rats. Int J Diabetes. 4:29–38.
   Google Scholar
• Shibib BA, Khan LA, Rahman R. 1993. Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenetic enzymes glucose-6-phosphatase and fructose-1,6-biphosphatase and elevation of both liver and red cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem J. 292:267–270.
   PubMed Web of Science ®Google Scholar
• Sitasawad SL, Shewade Y, Bhonde R. 2000. Role of bitter gourd fruit juice in STZ-induced diabetic state in vivo and in vitro. J Ethnopharmacol. 73:7–79.
   Web of Science ®Google Scholar
• Snedecor GW, Cochran WG. 1967 Statistical Methods. Ames, IA: Iowa State University Press, 6th ed, 593 pp.
   Google Scholar
• Srivastava Y, Venkatakrishna-Bhatt H, Verma Y, Venkaiah K. 1993. Antidiabetic and adaptogenic properties of Momordica charantia extract: An experimental and clinical evaluation. Phytother Res. 7:285–289.
   Web of Science ®Google Scholar
• Tikkanen T, Tikkanen I, Rockell MD, Allen TJ, Johnston CI, Cooper ME, Burrell LM. 1998. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus. Hypertension. 32:778–785.
   PubMed Web of Science ®Google Scholar
• Tiwari AK. 2007. A promising antidiabetic vegetable. Curr Sci. 92:12.
   Web of Science ®Google Scholar
• Virdi J, Sivakami S, Shahani S, Suthar AC, Banavalikar MM, Byanim MK. 2003. Antihyperglycemic effects of three extracts from Momordica charantia. J Ethnopharmacol. 88:107–111.
   PubMed Web of Science ®Google Scholar
• Wahren Ekberg K. 2007. Splanchnic regulation of glucose production. Annu Rev Nutr. 27:329–345.
   PubMed Web of Science ®Google Scholar
• Wong CM, Yeung HW, Ng TB. 1985. Screening of Trichosanthes kirilowii, Momordica charantia and Cucurbita maxima (family Cucurbitaceae) for compounds with antilipolytic activity. J Ethnopharmacol. 13:313–321.
   PubMed Web of Science ®Google Scholar
• Yadav UC, Moorthy K, Baquer NZ. 2005. Combined treatment of sodium orthovanadate and Momordica charantia fruit extract prevents alterations in lipid profile and lipogenic enzymes in alloxan diabetic rats. Mol Cell Biochem. 26:111–120.
   Google Scholar
• Yibchok-Anun S, Adisakwattana S, Yao CY, Sangvanich P, Roengsumran S, Hsu WH. 2006. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities. Biol Pharm Bull. 29:1126–1131.
   PubMed Web of Science ®Google Scholar